Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence - Test2 - elhamkhani - TriplyDB

Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence

Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence

http://www.wikidata.org/entity/Q25257162

about

Klebsiella pneumoniae: Going on the Offense with a Strong Defense Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study.Molecular epidemiology of multidrug resistant extended spectrum beta-lactamase producing Klebsiella pneumoniae at a Jamaican hospital, 2000-2004 Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital Allergic airway inflammation decreases lung bacterial burden following acute Klebsiella pneumoniae infection in a neutrophil- and CCL8-dependent manner.Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model.A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection Direct RNA-based detection and differentiation of CTX-M-type extended-spectrum β-lactamases (ESBL).Microbiological characteristics of sepsis in a University hospital Klebsiella pneumoniae oropharyngeal carriage in rural and urban Vietnam and the effect of alcohol consumption Surveillance of nosocomial infections in the Yaounde University Teaching Hospital, Cameroon Suspicion of respiratory tract infection with multidrug-resistant Enterobacteriaceae: epidemiology and risk factors from a Paediatric Intensive Care Unit Prevalence of Plasmid-Mediated Quinolone Resistance Genes among Extended-Spectrum β -Lactamase-Producing Klebsiella pneumoniae Human Isolates in Iran.Risk Factor Analysis in Clinical Isolates of ESBL and MBL (Including NDM-1) Producing Escherichia coli and Klebsiella Species in a Tertiary Care Hospital The continuing challenge of ESBLs.Controlling for severity of illness in outcome studies involving infectious diseases: impact of measurement at different time points.Clinical significance of extended-spectrum beta-lactamases.Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis.Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections.Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections.Development of a rapid diagnostic assay based on magnetic bead purification of OXA-β-lactamase mRNA.The Resistance Phenotype and Molecular Epidemiology of Klebsiella pneumoniae in Bloodstream Infections in Shanghai, China, 2012-2015 Klebsiella pneumoniae bloodstream infection, antimicrobial resistance and consumption trends in Ireland: 2008 to 2013.Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?Why hypothetical protein KPN00728 of Klebsiella pneumoniae should be classified as chain C of succinate dehydrogenase?Clinical impact of infections caused by ESBL-producing E. coli and K. pneumoniae.Mortality rate in neonates infected with extended-spectrum beta lactamase-producing Klebsiella species and selective empirical use of meropenem.The impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem: a hospital case study.Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis.Nosocomial Klebsiella pneumoniae bacteraemia in adult cancer patients--characteristics of neutropenic and non-neutropenic patients.Risk factors for acquiring extended-spectrum β-lactamase-producing Enterobacteriaceae in geriatric patients with multiple comorbidities in respiratory care wards.Invasive infection caused by Klebsiella pneumoniae is a disease affecting patients with high comorbidity and associated with high long-term mortality.Foodborne Nosocomial Outbreak of SHV1 and CTX-M-15-producing Klebsiella pneumoniae: Epidemiology and Control

P2860

Q26745802-2E0EF6E5-7CA3-4850-8160-B1BFD924EB2E Q33369556-356FBC77-0782-44C0-B065-899C2C908593 Q33527134-3789CDB2-45E1-46D8-9A5B-0D8597DE88FD Q34197909-8B4E8E58-2CF7-4DED-9A2E-7ADDE8EF0A94 Q34298356-4D0F64B3-23C9-45C2-9A24-97EF6DF45F3A Q34529381-3D558DDE-B83F-4CED-A569-4D903E53E183 Q34582295-A61AE035-A55E-400A-A71C-A8E62FDA37F4 Q35041607-4A62C115-8D5C-4695-A6CA-3602BB360844 Q35101906-CE08A205-E3AF-49D2-BBB1-45EF26DA339A Q35131377-37A9BF36-4D91-4FB0-A10A-1DAE618DACBD Q36216599-480DB488-8FE5-4951-9ADB-C9221A66A578 Q36286719-DCE3E0B5-CF02-4E80-9079-917043E04819 Q36290328-7179DF39-3462-45BC-A593-CBDEF58BF435 Q36343438-AC4F5DD0-2B2B-4EBE-A1EC-FE7830044871 Q36449603-7C9A33C9-D202-49F9-A044-42354ED0C554 Q37275990-0BC0E0C4-1A43-4F26-81F5-9613DF11D9E6 Q37291354-137B95D5-0277-48DB-A46D-21559517C428 Q37991287-5D4CEC0E-A0D6-42BE-BFE8-CC03D7FC95DB Q38048860-D351A75D-C20F-4DE5-BECD-884BC6220E47 Q38145311-F670F4ED-8128-4E99-B9C5-3F4E7F553B4F Q38869114-32DE42F0-65DA-412D-B96B-03CC4708EAC8 Q38915940-47A1A7D4-6BD7-4889-87FD-448762571AC3 Q39527751-BAE498C5-BECD-436D-9706-B128C2D02FCF Q40119449-7ECDEBE8-3A74-4A4B-B7DA-0EC9298494DF Q42099630-40E043D4-2CDF-4E0B-BABB-4725248DC254 Q43773083-45D9725F-EC47-4A99-A193-07F0F6127018 Q46002085-48F623BA-BA01-4886-9CB3-DC9945D5BF46 Q46067265-2E07BD15-555F-4B38-9504-E1C7EB18D192 Q48364629-C1A5DC4B-2659-40EF-BB32-C146A52661D9 Q48876913-5D9A3BC1-796E-4269-990D-BAAC14438E69 Q50894967-E9112FC9-1FB5-4938-9381-0B92332D15D7 Q55036941-5C0FE92A-931A-4CC3-8A98-F19FD498A2D9 Q58386884-B51FBD00-D5FA-4FD4-9CC7-C7431F821939

P2860

Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence

http://www.wikidata.org/entity/Q25257162

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Nosocomial bloodstream infecti ...... ital with high ESBL prevalence

@ast

Nosocomial bloodstream infecti ...... ital with high ESBL prevalence

@en

Nosocomial bloodstream infecti ...... ital with high ESBL prevalence

@nl

type

label

Nosocomial bloodstream infecti ...... ital with high ESBL prevalence

@ast

Nosocomial bloodstream infecti ...... ital with high ESBL prevalence

@en

Nosocomial bloodstream infecti ...... ital with high ESBL prevalence

@nl

prefLabel

Nosocomial bloodstream infecti ...... ital with high ESBL prevalence

@ast

Nosocomial bloodstream infecti ...... ital with high ESBL prevalence

@en

Nosocomial bloodstream infecti ...... ital with high ESBL prevalence

@nl

P1433

Q25257162-66549D8F-07D6-457D-A1D5-EBDC20A98460

P1476

Q25257162-DBE94229-9C63-4269-9DBC-483C820FEAEB

P2093

Q25257162-181AE439-A98C-42D0-A832-441907277C48

Q25257162-279B15AA-9330-43F0-8242-F2C59BB0DFC6

Q25257162-33E45387-384C-4534-B573-40E5D13560AE

Q25257162-B1FBCED7-C865-4F03-9D94-F52DAB7CC970

Q25257162-D0C939C1-5308-4918-8BAB-58DA9F8BB84A

Q25257162-E9040BEB-98CF-42E5-87C9-35CA1A5A84BC

P2860

Q25257162-03606048-66E4-4F34-BCC8-E67DE1205D87

Q25257162-1256C4AF-3E49-49F7-87CA-ECC13B87FA8F

Q25257162-136AE6FB-118D-457B-B36D-FE5660048D99

Q25257162-1DE85FD4-CABD-479D-81B1-F88B21BD146C

Q25257162-1E8FED1D-6D0D-42B0-BB4A-94BDBAC8534C

Q25257162-2EEA0821-76FF-4AEF-94B9-8C361C81FD43

Q25257162-2F499434-479B-4178-8CDD-F1F03DD847A9

Q25257162-36949701-3E9C-453E-95EB-FEB536A35A9C

Q25257162-40D4702E-5169-466A-93C4-7B663E800BF7

Q25257162-41F2E762-78AD-4308-AD8F-5BF4BF2DE02D

P2888

Q25257162-F1151EB5-A2F7-4C93-B6CB-C2E057AA1A97

P304

Q25257162-1BE1E68E-968F-470A-BF22-A45119693773

P31

Q25257162-7FDB63E5-86A4-4CFA-8B88-72059D605632

P356

Q25257162-56CF41AC-9243-4AAE-9950-1D7EE6C76E69

P407

Q25257162-8297EE34-696D-4F8A-9F95-C76254AC2F63

P433

Q25257162-6009B983-FB03-456E-808A-B14E51322D8B

P478

Q25257162-408F1B62-0EE9-4853-98D7-F1E5D1A07578

P50

Q25257162-6E947F0C-4A62-4E5D-9239-D657AFCEF816

Q25257162-DA558F8B-4746-4BFA-BBB7-D344D36F0E88

P577

Q25257162-93B38D1D-1403-4AE9-A378-FBF33952476D

P5875

Q25257162-F9D829A3-B1F1-4025-BAE3-30130DDCFDAA

P6179

Q25257162-F3C50E73-F2C9-4051-93A5-3D862E9777D2

P698

Q25257162-07C5D4CD-6524-4E27-8287-456D3BE2B0F9

P921

Q25257162-B97D8223-4905-431E-BC2B-27D72473769A

P932

Q25257162-8291D931-FE5A-4A1A-870B-27EA5355CDF1

P356

P1433

BMC Infectious Diseases

P1476

Nosocomial bloodstream infecti ...... ital with high ESBL prevalence

@en

P2093

Adauto Castelo

http://www.w3.org/2001/XMLSchema#string

Alexandre R Marra

http://www.w3.org/2001/XMLSchema#string

Carlos Alberto P Pereira

http://www.w3.org/2001/XMLSchema#string

José R do Carmo Filho

http://www.w3.org/2001/XMLSchema#string

Ruy Guilherme R Cal

http://www.w3.org/2001/XMLSchema#string

Sérgio B Wey

http://www.w3.org/2001/XMLSchema#string

P2860

A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study

Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997).

Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia.

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy.

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.

Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection.

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.

Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.

P2888

P304

24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-6-24

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Michael B Edmond

P577

2006-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7297554

http://www.w3.org/2001/XMLSchema#string

P6179

1005533375

http://www.w3.org/2001/XMLSchema#string

P698

16478537

http://www.w3.org/2001/XMLSchema#string

P921

Klebsiella pneumoniae

P932

1382232

http://www.w3.org/2001/XMLSchema#string